Enoxaparin for COVID-19: a systematic review and meta-analysis of randomized controlled trials

被引：0
|
作者：
Ehsan, Muhammad [1 ]
Jafar, Uzair [1 ]
Butt, Momina [1 ]
Naveed, Aiman [1 ]
Umer, Mohammad [1 ]
Ayyan, Muhammad [1 ]
Mustafa, Biah [1 ]
Awan, Rehmat Ullah [2 ]
机构：
[1] King Edward Med Univ, Dept Med, Div Infect Dis, Lahore 54000, Punjab, Pakistan
[2] Ochsner Rush Med Ctr, Dept Med, Meridian, MS USA
来源：
JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 2023年 / 56卷 / 03期
关键词：
OPEN-LABEL; ANTICOAGULATION; MULTICENTER; OUTPATIENTS;
D O I：
10.1007/s11239-023-02865-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：495 / 498
页数：4
相关论文
共 50 条
  • [41] Impact of uricosurics on mortality outcomes in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
    Kow, Chia Siang
    Ramachandram, Dinesh Sangarran
    Hasan, Syed Shahzad
    Thiruchelvam, Kaeshaelya
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2024, 32 (03) : 259 - 264
  • [42] The efficacy and safety of favipiravir in the treatment of nonsevere COVID-19: a systematic review and meta-analysis of randomized controlled trials
    Bahar, M. A.
    Kusuma, I. Y.
    Matuz, M.
    Ferenci, T.
    Benko, R.
    Csupor, D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1491 - 1491
  • [43] The efficiency of convalescent plasma in COVID-19 patients: A systematic review and meta-analysis of randomized controlled clinical trials
    Qian, Zhenbei
    Zhang, Zhijin
    Ma, Haomiao
    Shao, Shuai
    Kang, Hanyujie
    Tong, Zhaohui
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [44] The clinical efficacy of melatonin in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
    Huang, Po-Yu
    Wu, Jheng-Yan
    Liu, Ting-Hui
    Tsai, Ya-Wen
    Chen, Po-Tsang
    Liao, Chia-Te
    Toh, Han Siong
    FRONTIERS IN MEDICINE, 2023, 10
  • [45] The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Mohamed Abuelazm
    Ahmed Ghanem
    Ahmed K. Awad
    Ramadan Abdelmoez Farahat
    Fatma Labieb
    Basant E. Katamesh
    Basel Abdelazeem
    Clinical Drug Investigation, 2022, 42 : 1031 - 1047
  • [46] Efficacy and Safety of Favipiravir for the Treatment of COVID-19 Outpatients: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Cheema, Huzaifa Ahmad
    Ali, Abraish
    Ali, Mirha
    Shahid, Abia
    Ghafoor, Muhammad Saqib
    Ur Rehman, Mohammad Ebad
    Sah, Ranjit
    Sahra, Syeda
    Ahmad, Sharjeel
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (03) : e328 - e331
  • [47] Molnupiravir for treatment of adults with mild or moderate COVID-19: a systematic review and meta-analysis of randomized controlled trials
    Gao, Ya
    Liu, Ming
    Li, Zhifan
    Xu, Jianguo
    Zhang, Junhua
    Tian, Jinhui
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (08) : 979 - 999
  • [48] The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
    Lai, Chih-Cheng
    Chen, Wang-Chun
    Chen, Ching-Yi
    Wei, Yu-Feng
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (10) : 1333 - 1340
  • [49] Antiplatelet therapy for patients with COVID-19: Systematic review and meta-analysis of observational studies and randomized controlled trials
    Zong, Xiaolong
    Wang, Xiao
    Liu, Yaru
    Li, Zhenyu
    Wang, Weiding
    Wei, Dianjun
    Chen, Zhuqing
    FRONTIERS IN MEDICINE, 2022, 9
  • [50] Mesenchymal Stem Cells on Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Qin, Jinlv
    Wang, Guizuo
    Han, Dong
    STEM CELL REVIEWS AND REPORTS, 2024, 20 (04) : 931 - 937
12345